IBO · AMEX
Impact BioMedical (IBO) Stock Price & Fundamentals
Impact BioMedical (IBO) closed at $174.65 on Oct 9, 2026, down 0.25% from the previous close of $175.08.
Share price, past year
1Y +4.30%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $174.65 |
| Sep 30, 2026 | $174.29 |
| Aug 31, 2026 | $170.81 |
| Jul 31, 2026 | $167.69 |
| Jun 30, 2026 | $179.92 |
| May 29, 2026 | $186.51 |
| Apr 30, 2026 | $178.28 |
| Mar 31, 2026 | $168.34 |
| Feb 27, 2026 | $173.39 |
| Jan 30, 2026 | $168.61 |
| Dec 31, 2025 | $165.55 |
| Nov 28, 2025 | $158.35 |
| Oct 31, 2025 | $163.02 |
Key statistics
- Market cap
- $18.83B
- P/E (TTM)
- 198.5
- EPS (TTM)
- $0.88
- Revenue (TTM)
- —
- Net income (TTM)
- $789.00K
- Shares outstanding
- 107.8M
- Dividend yield
- —
- 52-week range
- $157.02 – $186.58
Impact BioMedical's market cap is $18.83B, based on a share price of $174.65 and 107.8M shares outstanding as of Jun 30, 2026.
Financials
Impact BioMedical reported revenue of $32.00K for fiscal 2025.
Impact BioMedical reported a net loss of $11.84M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $32.00K | −36.0% | −$11.84M | −36,993.8% | −$0.38 | — |
| FY2022ended Dec 31, 2022 | $50.00K | — | −$7.26M | −14,510.0% | −$0.10 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $3.00K | −$699.00K | −$0.01 |
| Q1 FY2026ended Mar 31, 2026 | $7.00K | −$2.29M | −$0.02 |
| Q3 FY2025ended Sep 30, 2025 | $18.00K | −$1.47M | −$0.12 |
| Q2 FY2025ended Jun 30, 2025 | $7.00K | −$14.35M | −$1.18 |
| Q2 FY2022ended Jun 30, 2022 | $50.00K | — | — |
Company profile
- Name
- Impact BioMedical, Inc.
- Ticker
- IBO
- Exchange
- AMEX
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1400 Broadfield Blvd., Suite 130, Houston, TX 77084
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001834105
Recent SEC filings
- Sep 17, 2026
- Sep 15, 2026
- Aug 7, 2026
- May 12, 2026
- Mar 11, 2026
- Mar 4, 2026
- Nov 7, 2025
- Nov 6, 2025
Frequently asked questions
What is Impact BioMedical's stock price?
Impact BioMedical (IBO) closed at $174.65 on Oct 9, 2026, down 0.25% from the previous close of $175.08.
What is Impact BioMedical's market cap?
Impact BioMedical's market cap is $18.83B, based on a share price of $174.65 and 107.8M shares outstanding as of Jun 30, 2026.
How much revenue does Impact BioMedical make?
Impact BioMedical reported revenue of $32.00K for fiscal 2025.
What is IBO's P/E ratio?
Impact BioMedical's price-to-earnings ratio is 198.5, based on trailing twelve-month diluted EPS of $0.88.
Does Impact BioMedical pay a dividend?
Impact BioMedical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Impact BioMedical, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures